| Ascension At Home | |
| 1035 North Emporia, Suite 230, Wichita, Kansas 67214 | |
| (316) 268-8588 | |
| Name | Ascension At Home |
|---|---|
| Location | 1035 North Emporia, Suite 230, Wichita, Kansas |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 177117 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 67001, 67002, 67010, 67013, 67016, 67017, 67020, 67025, 67026, 67030, 67031, 67037, 67039, 67042, 67050, 67052, 67056, 67060, 67062, 67067, 67074, 67101, 67108, 67110, 67114, 67117, 67118, 67119, 67120, 67123, 67133, 67135, 67142, 67144, 67146, 67147, 67149, 67151, 67152, 67156, 67202, 67203, 67204, 67205, 67206, 67207, 67208, 67209, 67210, 67211, 67212, 67213, 67214, 67215, 67216, 67217, 67218, 67219, 67220, 67223, 67226, 67227, 67228, 67230, 67232, 67235, 67543, 67570 |
| NPI Number | 1235132119 |
| Organization Name | VIA CHRISTI HOME HEALTH WICHITA, LLC |
| Doing Business As | ASCENSION AT HOME |
| Address | 301 N Main St Ste 950, Wichita, KS 67202 |
| Phone Number | 316-268-8588 |
News Archive
Researchers at Fox Chase Cancer Center in Philadelphia have come a step closer to understanding selenium's molecular role in causing prostate cancer cells to self-destruct. According to data presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif., selenium helps malignant cells overcome their resistance to TRAIL-induced apopstosis (self-inflicted cell death).
The identification of more than 200 new proteins that interact with the mutated protein that causes Huntington's disease opens the door to developing treatments for the fatal neurodegenerative disorder, said a Baylor College of Medicine researcher who took part in the work that appears online today in the journal Public Library of Science Genetics.
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
With our unique team and the power of the recent revolution in immersive reality technology, we are finally able to address these issues by providing a highly mobile, hands-on, realistic training platform that allows practitioners to learn or review complex surgical procedures without risking patient safety.
A swaying tree and a moving person activate distinctive areas of the brain's visual cortex, since recognizing people is essential for social interaction. So, an important question in exploring the visual system is how the visual cortex manages such specific recognition of "biological motion."
› Verified 8 days ago
| Quality Rating: |
News Archive
Researchers at Fox Chase Cancer Center in Philadelphia have come a step closer to understanding selenium's molecular role in causing prostate cancer cells to self-destruct. According to data presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif., selenium helps malignant cells overcome their resistance to TRAIL-induced apopstosis (self-inflicted cell death).
The identification of more than 200 new proteins that interact with the mutated protein that causes Huntington's disease opens the door to developing treatments for the fatal neurodegenerative disorder, said a Baylor College of Medicine researcher who took part in the work that appears online today in the journal Public Library of Science Genetics.
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
With our unique team and the power of the recent revolution in immersive reality technology, we are finally able to address these issues by providing a highly mobile, hands-on, realistic training platform that allows practitioners to learn or review complex surgical procedures without risking patient safety.
A swaying tree and a moving person activate distinctive areas of the brain's visual cortex, since recognizing people is essential for social interaction. So, an important question in exploring the visual system is how the visual cortex manages such specific recognition of "biological motion."
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 97.4 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 99.9 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.3 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 86.5 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.2 | 96.4 |
News Archive
Researchers at Fox Chase Cancer Center in Philadelphia have come a step closer to understanding selenium's molecular role in causing prostate cancer cells to self-destruct. According to data presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif., selenium helps malignant cells overcome their resistance to TRAIL-induced apopstosis (self-inflicted cell death).
The identification of more than 200 new proteins that interact with the mutated protein that causes Huntington's disease opens the door to developing treatments for the fatal neurodegenerative disorder, said a Baylor College of Medicine researcher who took part in the work that appears online today in the journal Public Library of Science Genetics.
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
With our unique team and the power of the recent revolution in immersive reality technology, we are finally able to address these issues by providing a highly mobile, hands-on, realistic training platform that allows practitioners to learn or review complex surgical procedures without risking patient safety.
A swaying tree and a moving person activate distinctive areas of the brain's visual cortex, since recognizing people is essential for social interaction. So, an important question in exploring the visual system is how the visual cortex manages such specific recognition of "biological motion."
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 78.2 | 79.6 |
| How often patients got better at getting in and out of bed | 80.8 | 81.1 |
| How often patients got better at bathing | 83.4 | 82.3 |
| How often patients’ breathing improved | 85.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 93.1 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 73.6 | 75 |
| How often home health patients had to be admitted to the hospital | 16.2 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.2 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98.2 | 94 |
News Archive
Researchers at Fox Chase Cancer Center in Philadelphia have come a step closer to understanding selenium's molecular role in causing prostate cancer cells to self-destruct. According to data presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif., selenium helps malignant cells overcome their resistance to TRAIL-induced apopstosis (self-inflicted cell death).
The identification of more than 200 new proteins that interact with the mutated protein that causes Huntington's disease opens the door to developing treatments for the fatal neurodegenerative disorder, said a Baylor College of Medicine researcher who took part in the work that appears online today in the journal Public Library of Science Genetics.
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
With our unique team and the power of the recent revolution in immersive reality technology, we are finally able to address these issues by providing a highly mobile, hands-on, realistic training platform that allows practitioners to learn or review complex surgical procedures without risking patient safety.
A swaying tree and a moving person activate distinctive areas of the brain's visual cortex, since recognizing people is essential for social interaction. So, an important question in exploring the visual system is how the visual cortex manages such specific recognition of "biological motion."
› Verified 8 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Researchers at Fox Chase Cancer Center in Philadelphia have come a step closer to understanding selenium's molecular role in causing prostate cancer cells to self-destruct. According to data presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif., selenium helps malignant cells overcome their resistance to TRAIL-induced apopstosis (self-inflicted cell death).
The identification of more than 200 new proteins that interact with the mutated protein that causes Huntington's disease opens the door to developing treatments for the fatal neurodegenerative disorder, said a Baylor College of Medicine researcher who took part in the work that appears online today in the journal Public Library of Science Genetics.
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
With our unique team and the power of the recent revolution in immersive reality technology, we are finally able to address these issues by providing a highly mobile, hands-on, realistic training platform that allows practitioners to learn or review complex surgical procedures without risking patient safety.
A swaying tree and a moving person activate distinctive areas of the brain's visual cortex, since recognizing people is essential for social interaction. So, an important question in exploring the visual system is how the visual cortex manages such specific recognition of "biological motion."
› Verified 8 days ago
The patient survey data of Ascension At Home is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 84 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 86 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 80 | 78 |
News Archive
Researchers at Fox Chase Cancer Center in Philadelphia have come a step closer to understanding selenium's molecular role in causing prostate cancer cells to self-destruct. According to data presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif., selenium helps malignant cells overcome their resistance to TRAIL-induced apopstosis (self-inflicted cell death).
The identification of more than 200 new proteins that interact with the mutated protein that causes Huntington's disease opens the door to developing treatments for the fatal neurodegenerative disorder, said a Baylor College of Medicine researcher who took part in the work that appears online today in the journal Public Library of Science Genetics.
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
With our unique team and the power of the recent revolution in immersive reality technology, we are finally able to address these issues by providing a highly mobile, hands-on, realistic training platform that allows practitioners to learn or review complex surgical procedures without risking patient safety.
A swaying tree and a moving person activate distinctive areas of the brain's visual cortex, since recognizing people is essential for social interaction. So, an important question in exploring the visual system is how the visual cortex manages such specific recognition of "biological motion."
› Verified 8 days ago
Interim Healthcare Of Wichita Location: 9920 East Harry Street, Wichita, Kansas 67207 Ratings: Phone: (316) 265-4295 | |
Ascension At Home Location: 1035 North Emporia, Suite 230, Wichita, Kansas 67214 Ratings: Phone: (316) 268-8588 | |
Amedisys Home Health Care Location: 250 W Douglas, Suite 101, Wichita, Kansas 67202 Ratings: NA Phone: (316) 945-9797 | |
Heartland Hh Care & Hospice Location: 2872 N. Ridge Road, Suite 122, Wichita, Kansas 67205 Ratings: Phone: (316) 788-7626 | |
Encompass Health Home Health Location: 8201 E. 34th Street Circle N., Suite 1503, Wichita, Kansas 67226 Ratings: Phone: (316) 267-4663 | |
Progressive Home Health & Hospice Location: 3500 North Rock Road Building 400, Wichita, Kansas 67226 Ratings: Phone: (316) 691-5050 |